Watts Adam C, Hamoodi Zaid, Wright Andrew C, McDaid Catriona M, Hewitt Catherine E
Health Research Institute, Edge Hill University, Ormskirk, UK.
Upper Limb Unit, Wrightington Hospital, Wigan, UK.
Shoulder Elbow. 2025 Mar 25:17585732251328594. doi: 10.1177/17585732251328594.
Unreconstructible distal humerus fractures have been managed with total elbow replacement (TER), but there is increasing use of hemi-replacement (DHH). Pain has been identified as the most important outcome by patients. This study aims to systematically review the literature on reported pain outcomes in adult distal humerus fractures treated with TER or DHH.
Medline, Embase and Central were searched using OVID, from January 2000 to September 2023, for studies in adults undergoing DHH or TER for acute closed distal humerus fractures. The primary outcome was patient-rated pain measured on a numerical rating scale. A quantitative summary of reported outcomes was stratified by intervention type.
Twenty-three studies met the inclusion criteria, including one published randomised controlled trial. Meta-analysis found a pooled average NRS pain for TER of 1.7/10 (95% CI: 0.44-2.99) and 1.5/10 for DHH (95% CI: 0.001-3.56). On a 4-point Likert scale the pooled probability of no pain, mild pain, moderate pain, severe pain for TER was 0.75, 0.21, 0.02, 0.00 and for DHH was 0.76, 0.11, 0.12, and 0.00.
The available evidence does not enable comparison of pain outcomes between the interventions, which should be assessed in an appropriately powered randomised trial.
不可重建的肱骨远端骨折一直采用全肘关节置换术(TER)进行治疗,但半关节置换术(DHH)的使用越来越多。疼痛已被患者确定为最重要的预后指标。本研究旨在系统回顾关于TER或DHH治疗成人肱骨远端骨折的疼痛预后的文献。
使用OVID检索2000年1月至2023年9月期间的Medline、Embase和Central数据库,以查找接受DHH或TER治疗急性闭合性肱骨远端骨折的成人研究。主要结局是采用数字评分量表测量的患者自评疼痛。报告结局的定量汇总按干预类型分层。
23项研究符合纳入标准,包括1项已发表的随机对照试验。荟萃分析发现,TER的合并平均NRS疼痛评分为1.7/10(95%CI:0.44-2.99),DHH为1.5/10(95%CI:0.001-3.56)。在4点李克特量表上,TER无疼痛、轻度疼痛、中度疼痛、重度疼痛的合并概率分别为0.75、0.21、0.02、0.00,DHH分别为0.76、0.11、0.12和0.00。
现有证据无法比较不同干预措施之间的疼痛预后,应在一项有足够效力的随机试验中进行评估。